Carlos Finlay

From WikiMD's WELLNESSPEDIA

Carlos Finlay (December 3, 1833 – August 20, 1915) was a Cuban epidemiologist recognized as a pioneer in the research of yellow fever, identifying mosquitoes as the disease's primary vector. His work laid the foundation for the eventual eradication of yellow fever.

Early Life and Education[edit]

Carlos Juan Finlay was born in Camagüey, Cuba, on December 3, 1833, to a French mother and Scottish father. He moved to Europe for his education, studying at the renowned French and German schools. He later moved to the United States to study medicine at the Jefferson Medical College in Philadelphia.

Career[edit]

Finlay began his medical career in Havana, where he opened a private practice in 1864. He became deeply interested in the study of yellow fever, a disease that was causing devastating epidemics in Cuba and other parts of the Americas.

In 1881, Finlay presented his theory that mosquitoes were the primary vector of yellow fever, a revolutionary idea at the time. Despite initial skepticism, his theory was eventually accepted and formed the basis for the successful control of the disease.

Legacy[edit]

Carlos Finlay's work has had a profound impact on public health. His discovery has saved countless lives and his methods are still used today in the fight against diseases transmitted by mosquitoes, such as dengue fever and Zika virus.

See Also[edit]

References[edit]

  • Carlos J. Finlay: His Life and His Work by Gustavo Pittaluga (1945)
  • The Mosquito Crusades: A History of the American Anti-Mosquito Movement from the Reed Commission to the First Earth Day by Gordon Patterson (2009)


Carlos Finlay[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.